We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ADCT ADC Therapeutics SA

0.28 (33.73%)
After Hours
Last Updated: 16:39:16
Delayed by 15 minutes


Draw Mode:

Volume 1,173,995
Bid Price
Ask Price
News -
Day High 1.15


52 Week Range


Day Low 0.83
Company Name Stock Ticker Symbol Market Type
ADC Therapeutics SA ADCT NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
0.28 33.73% 1.11 16:39:16
Open Price Low Price High Price Close Price Prev Close
0.83 0.83 1.15 1.11 0.83
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
3,726 1,173,995 $ 1.00 $ 1,178,868 - 0.359908 - 5.75
Last Trade Time Type Quantity Stock Price Currency
17:37:00 14 $ 1.10 USD

ADC Therapeutics SA Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
89.51M 80.64M - 209.91M -155.8M -1.93 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

ADC Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No ADCT Message Board. Create One! See More Posts on ADCT Message Board See More Message Board Posts

Historical ADCT Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.691.150.68830.7998831322,7000.4260.87%
1 Month0.70311.150.3599080.6533334384,7540.406957.87%
3 Months1.081.150.3599080.7470432308,1350.032.78%
6 Months2.352.640.3599081.35387,648-1.24-52.77%
1 Year3.695.750.3599082.47548,701-2.58-69.92%
3 Years37.3338.340.35990810.02357,852-36.22-97.03%
5 Years30.0056.58990.35990812.83337,154-28.89-96.3%

ADC Therapeutics Description

ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602, ADCT-601, ADCT-901, ADCT-701 and ADCT-212.

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 |